小分子调节开关,为患者内部的CAR T细胞提供功能控制
Charlotte U Zajc1,2, Elise Sylvander2,3, Manfred Lehner2,3,4
1Department of Chemistry, Institute of Biochemistry, BOKU University, Vienna, Austria.
Expert opinion on biological therapy
|June 29, 2024
概括
化学抗原受体 (CAR) T细胞疗法显示出有希望的结果,但缺乏控制. 小分子调节开关系统为管理这些活药物和推进未来的CAR T细胞疗法提供了潜在的解决方案.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在治疗某些血液癌症方面表现出显著的疗效.
- 卡尔-T细胞是被设计成活体药物,在药物注射后控制它们的活动方面存在挑战.
研究的目的:
- 探索小型分子调节开关系统来控制CAR T细胞功能.
- 确定CAR T细胞治疗中的关键障碍,这些切换系统可以解决.
主要方法:
- 小分子调节开关系统的讨论.
- 对CAR T细胞治疗当前挑战的分析.
主要成果:
- 小分子开关在体内为调节CAR T细胞活动提供了一个潜在的机制.
- 这些系统可能有助于克服CAR T细胞临床应用中的关键限制.
结论:
- 需要先进的开关系统来增强CAR T细胞疗法.
- 预计这些系统的开发将为下一代CAR T细胞疗法铺平道路.
相关概念视频
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.